Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 11, 2020

Strategikon releases Clinical Maestro LEAD for trial budget management

Strategikon Pharma has released Cloud-based platform Clinical Maestro LEAD for ongoing trial budget management.

Strategikon Pharma has released Cloud-based platform Clinical Maestro LEAD for ongoing trial budget management.

Clinical Maestro LEAD drives transparency and continuity into the trial accrual reporting, as well as forecasting process.

It helps sponsors attain ‘budget certainty’ and make informed decisions. It will also identify risks sooner to maximise what is seen.

Strategikon Pharma founder and CEO Anca Copaescu said: “Input from our life sciences customers is that only tracking project milestones doesn’t offer enough insight into the actual completed tasks and study progress.

“They need to know what has been spent against what was planned without turning their entire team upside down. Clinical Maestro LEAD offers a new, modern approach to budget spend analysis and accrual reporting by introducing system-driven due diligence, and multi-dimensional spend and operational driver comparisons.

“This provides greater visibility into the timing and rate of expense. Having access to earned value analysis (EVA) in real-time keeps study teams ahead of the change curve and decreases incidence of unnecessary change orders.”

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Why Asia-Pacific is the next frontier for decentralized clinical trials

Clinical Maestro is an end-to-end Cloud-based platform to more efficiently budget, source, and manage complex clinical programmes. It added LEAD module to modernise the process of accrual and reforecasting for clinical trials.

Strategikon Pharma CCO Farah Ahmad said: “With the complexity level of today’s clinical trials, the use of manual, static tools like Excel to manage budgets is unsustainable. Especially with the impact of Covid-19, understanding forecast changes is critical.

“Clinical Maestro LEAD automates the entire EVA process with structured actual spend reporting and metrics so sponsors can bring order to their accrual and forecast process. Ultimately, sponsors get greater transparency that helps to deepen their Provider Partnerships.”

LEAD is part of the Clinical Maestro Sponsor Edition, which is a set of unified clinical business operations applications for managing clinical trials on a single Cloud-based platform.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU